Clinical Trial Update: Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of 2-HOBA on persistent immune activation in Long COVID with Postural Tachycardia Syndrome; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute COVID-19 Syndrome
• Postural Tachycardia Syndrome

Drugs mentioned

• 2-HOBA (2-HOBA (2-hydroxybenzylamine))

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS) | Phase 2 | Status: RECRUITING